Appendix Table 1. List of ICD-9/10 codes used for ... - Semantic Scholar

1 downloads 0 Views 177KB Size Report
Appendix Table 1. List of ICD-9/10 codes used for identifying multiple sclerosis, demyelinating diseases and Drug Identification Numbers (DIN) for identifying the.
APPENDIX: Appendix Table 1. List of ICD-9/10 codes used for identifying multiple sclerosis, demyelinating diseases and Drug Identification Numbers (DIN) for identifying the disease-modifying drugs licensed for multiple sclerosis Demyelinating-related disease or drug description

ICD-9 codes

ICD-10 codes

340

G35

Optic neuritis

377.3

H46

Acute transverse myelitis

323.82

G37

323

G36.9

Demyelinating disease of CNS unspecified

341.9

G37.8

Neuromyelitis optica

341.0

G36.0

341

G36

Multiple Sclerosis

Acute disseminated encephalomyelitis

Other acute disseminated demyelination

glatiramer acetate, beta-interferon, natalizumb, fingolimod

Drug Identification Numbers (DIN)

02169649 02233014 02237317 02237319 02237320 02237770 02245619 02269201 02277492 02281708 02286386 02318253 02318261 02337819 02365480

1

Appendix Table 2. Additional characteristics of the cohort with multiple sclerosis (MS). Characteristics

No. (%)

(n=360) Ever on MS disease-modifying treatments at index date* Yes 115 (31.9) No 245 (68.1) Age of parent at MS onset 0-4 years 31 (8.6) 5-9 years 210 (58.3) ≥10 years 119 (33.1) Median [range] 8.5 [4.1 - 24.1 years] *n=30 (26%) were ever exposed to glatiramer acetate and n= 85 (74%) to a betainterferon

Appendix Table 3. Rates of peripartum depression by parental MS status and history of depression or anxiety in the 2 years prior to the peripartum period, British Columbia, Canada Peripartum depression History of depression or anxiety Mothers Fathers No history of depression or anxiety Mothers Fathers

Parent with multiple sclerosis No. (%) 76 (34.2%) 54 (33.1%) 22 (37.3%)

Matched reference cohort No. (%) 184 (27.0%) 163 (28.4%) 21 (19.1%)

17 (12.3%) 12 (13.4%) 5 (10.9%)

39 (7.4%) 29 (8.8%) 10 (5.1%)

2